Green Thumb Industries (GTBIF) Other Operating Expenses (2020 - 2026)
Green Thumb Industries (GTBIF) posted Other Operating Expenses of $17.0 million for Q1 2026, down 80.79% on a QoQ basis from $88.5 million in Q4 2022.
Green Thumb Industries (GTBIF) Other Operating Expenses (2020 - 2026) Analysis & Trends
Green Thumb Industries' Other Operating Expenses history runs 4 years deep, the most recent figure standing at $17.0 million for Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to $17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (changed N/A YoY) and the FY2022 annual result came in at $88.5 million, changed N/A from the prior year.
- Other Operating Expenses was $17.0 million for Q1 2026 at Green Thumb Industries, down from $88.5 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $88.5 million in Q4 2022 and bottomed at $17.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2022 | 88.50 Mn |
| Mar 31, 2022 | 65.00 Mn |
| Sep 30, 2021 | -249,078.00 |
| Dec 31, 2020 | 9.45 Mn |
| Sep 30, 2020 | 442,991.00 |
| Jun 30, 2020 | -188,555.00 |